Fibrinogen concentrate in bleeding patients

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Wikkelsø, Anne ^a   Lunde, Jens ^b   Johansen, Mathias ^b   Stensballe, Jakob ^b   Wetterslev, Jørn ^b   Møller, Ann Merete ^a   Afshari, Arash ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN CONCENTRATE; PLACEBO; FIBRINOGEN;

ALL CAUSE MORTALITY; BLEEDING; BLOOD TRANSFUSION; CLINICAL OUTCOME; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HUMAN; INCIDENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ADULT; CHILD; ELECTIVE SURGERY; HEART SURGERY; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTILIZATION REVIEW; HEMORRHAGE; UTILIZATION;

ADULT; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHILD; FIBRINOGEN; HEMORRHAGE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL PROCEDURES, ELECTIVE; ELECTIVE SURGICAL PROCEDURES;

EID: 84893406145     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008864.pub2     Document Type: Review

References (105)

1. Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, et al. Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. Artificial Organs 2010;34(11):955-60. [MEDLINE: 21092037]
2. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. Journal of Thrombosis and Haemostasis 2009;7:795-802. [MEDLINE: 19320829]
3. Galas F, Hajjar L, Sorensen B, Almeida J, Sundin M, Guimaraes V, et al. Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study). Critical Care 2012;16(Suppl 1):P438. [DOI: 10.1186]
4. Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thrombosis and Haemostasis 2009;102:137-44. [MEDLINE: 19572078]
5. Karlsson M, Ternström L, Hyllner M, Baghaei F, Skrtic S, Jeppson A. Prophylactic fibrinogen Infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis, and platelet function. Clinical and Applied Thrombosis/Hemostasis 2011;17(4):396-404. [MEDLINE: 20530054]
6. Lance MD, Ninivaggi M, Schols SE, Feijge MA, Oehrl SK, Kuiper GJ, et al. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial. Vox Sanguinis 2012;103(1):25-34. [PUBMED: 22211833]
7. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013;118(1):40-50. [PUBMED: 23249928]
8. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Pichlmaier M. Efficacy and safety of fibrinogen concentrate in the treatment of major bleeding during cardiac surgery: results of a randomized, placebo-controlled trial. No. LBC07. American Society of Anesthesiologists Annual Meeting, october 15-19, 2011; Chicago Illinois, USA. [http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=33D06092FED7196AF490D3E3FBAB06B3?year=2011&index=6&absnum=7668]
9. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. International Journal of Obstetrical Anesthesiology 2010;19(2):218-23. [MEDLINE: 20194010]
10. Danés AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sanguinis 2008;94:221-6. [MEDLINE: 18179679]
11. Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia 2010;65:1229-30. [MEDLINE: 21182609]
12. Guasch E, Alsina E, Diez J, Ruiz R, Gilsanz F. [Postpartum hemorrhage: an observational study of 21, 726 deliveries in 28 months] [Hemorragia obstetrica: estudio observacional sobre 21.726 partos en 28 meses.]. Revista Espanola de Anestesiologia y Reanimacion 2009;56(3):139-46. [PUBMED: 19408780]
13. Haas T, Fries D, Velik-Salchner C, Oswald E, Innerhofer P. Fibrinogen in craniosynostosis surgery. Anesthesia and Analgesia 2008;106(3):725-31, table of contents. [PUBMED: 18292409]
14. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia 2007;105(4):905-17. [MEDLINE: 17898365]
15. Morrison GA, Chalmers RT, Solomon C, Nimmo AF. Fibrinogen concentrate therapy guided by thromboelastometry as an alternative to fresh frozen plasma in major vascular surgery. Journal of Cardiothoracic and Vascular Anesthesia 2012;26(4):654-9. [PUBMED: 21955829]
16. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. British Journal of Anaesthesia 2009;102(6):785-92. [PUBMED: 19411671]
17. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. The Journal of Thoracic and Cardiovascular Surgery 2009;138(3):694-702. [PUBMED: 19698858]
18. Schochl H, Forster L, Woidke R, Solomon C, Voelckel W. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010;65(2):199-203. [PUBMED: 19995349]
19. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Critical Care (London, England) 2010;14(2):R55. [PUBMED: 20374650]
20. Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. British Journal of Anaesthesia 2010;104(5):555-62. [PUBMED: 20348140]
21. Thorarinsdottir HR, Sigurbjornsson FT, Hreinsson K, Onundarson PT, Gudbjartsson T, Sigurdsson GH. Effects of fibrinogen concentrate administration during severe hemorrhage. Acta Anaesthesiologica Scandinavica 2010;54(9):1077-82. [PUBMED: 20887409]
22. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfusion Medicine (Oxford, England) 2008;18(3):151-7. [PUBMED: 18598277]
23. Galas F, Hajjar L, Sorensen B, Almeida J, Sundin M, Guimaraes V, et al. Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study). Critical Care 2012;16:S156-7.
24. Rahe-Meyer N. Fibrinogen Concentrate in the Treatment of Severe Bleeding After Aortic Aneurysm Graft Surgery. Thrombosis Research 2011;128:S17-9.
25. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. Haemostatic therapy with fibrinogen concentrate for controlling major bleeding during complex cardiovascular surgery: Results of a randomised, placebo-controlled trial. British Journal of Anaesthesia 2012;108:ii86.
26. Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: Results from a randomized, placebo-controlled trial. Journal of Thoracic and Cardiovascular Surgery 2013;145:S178-85.
27. Solomon C, Schoechl H, Hagl C, Rahe-Meyer N. Fibrinogen concentrate as first-line haemostatic therapy during aortic replacement surgery. A randomised trial. Journal of Thrombosis and Haemostasis 2012;10:e7.
28. Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC). Ongoing study October 2011.
29. Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy: FibPaed Study. Ongoing study January 2012.
30. RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma. Ongoing study March 2012.
31. Fibrinogen and Bleeding After Cardiac Surgery (Fibro-3). Ongoing study April 2009.
32. Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery. Ongoing study Not yet recruiting.
33. Haemocomplettan sup ®/sup P During Elective Complex Cardiac Surgery. Ongoing study February 2011.
34. Fibrinogen as an Alternative to Fresh Frozen Plasma in Aortic Surgery. Ongoing study October 2009.
35. The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery. Ongoing study November 2011.
36. The Efficacy of the Administration of Fibrinogen in Liver Transplantation (FibstudLT). Ongoing study March 2012.
37. RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery (RiaCT). Ongoing study January 2011.
38. Wikkelsoe AJ, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, Ekelund K, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 2012;13(1):110. [PUBMED: 22805300]
39. The American Society of Anesthesiologists. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208. [MEDLINE: 16810012]
40. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis 2005;93:1101-7. [MEDLINE: 15968395]
41. Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disordersreview with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004;10(5):593-628. [PUBMED: 15357789]
42. Bornikova L, Peyvandi F, Allen G, Bernstein J, Manco-Johnson MJ. Fibrinogen replacement therapy for congenital fibrinogen deficiency. Journal of Thrombosis and Haemostasis 2011;9(9):1687-704. [PUBMED: 21711446]
43. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. The Journal of Trauma 2008;64(1529-8809 (Electronic), 5):1211-7. [MEDLINE: 18469643]
44. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-9. [MEDLINE: 18411040]
45. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. The New England Journal of Medicine 2011;365(26):2453-62. [PUBMED: 22168590]
46. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3]
47. Caudill JS, Nichols WL, PlumhoffEA, Schulte SL, Winters JL, Gastineau DA, et al. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion 2009;49(4):765-70. [PUBMED: 19192257]
48. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291(20):2457-65. [MEDLINE: 15161896]
49. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007;5:266-73. [MEDLINE: 17087729]
50. de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thrombosis and Haemostasis 1998;79(0340-6245 (Print), 0340-6245 (Linking), 2):286-90. [MEDLINE: 9493577]
51. Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sorensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. British Journal of Anaesthesia 2005;94:324-9. [MEDLINE: 15608046]
52. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. British Journal of Anaesthesia 2008;101:769-73. [MEDLINE: 18818192]
53. Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate-a potential universal hemostatic agent. Expert Opinion on Biological Therapy 2009;9(10):1325-33. [MEDLINE: 19645632]
54. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch induced dilutional coagulopathy. Journal of Thrombosis and Haemostasis 2009;7(7):1099-105. [MEDLINE: 19422451]
55. Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V, et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. British Joural of Anaesthesia 2005;95:172-7. [MEDLINE: 15923269]
56. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy-a porcine model. British Journal of Anaesthesia 2006;97:460-7. [MEDLINE: 16885172]
57. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. British Journal of Anaesthesia 2010;105(2):116-21. [PUBMED: 20627882]
58. GradePro Working Team. GRADEPro. 3.2 for Windows. GradePro Working Team, 2008, http://ims.cochrane.org/revman/other-resources/gradepro/download.
59. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(1468-5833 (Electronic), 0959-535X (Linking), 7651):995-8. [MEDLINE: 18456631]
60. Haas T, Fries D, Velik-Salchner C, Reif C, Klingler A, Innerhofer P. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesthesia and Analgesia 2008;106:1360-5. [MEDLINE: 18420845]
61. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England Journal of Medicine 1999;340(6):409-17. [PUBMED: 9971864]
62. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
63. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 1995;81:360-5. [MEDLINE: 7542432]
64. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagulation & Fibrinolysis 1995;6:743-6. [MEDLINE: 8825225]
65. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. British Journal of Obstetrics and Gynecology 2009;116:1097-102. [MEDLINE: 19459866]
66. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Journal of the Royal Statistical Society Series C 2000;49:359-70. [MEDLINE: 11122498]
67. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Statistics in Medicine 1999;18(15):1905-42. [PUBMED: 10532877]
68. Jansen JO, Thomas R, Loudon MA, Brooks A. Damage control resuscitation for patients with major trauma. British Medical Journal 2009;338:b1778. [MEDLINE: 19502278]
69. Kalina U, Stohr HA, Bickhard H, Knaub S, Siboni SM, Mannucci PM, et al. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagulation & Fibrinolysis 2008;19:777-83. [MEDLINE: 19002044]
70. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008;48:2152-8. [MEDLINE: 18657083]
71. Kozek-Langenecker S, Sorensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Critical Care (London, England) 2011;15(5):R239. [PUBMED: 21999308]
72. Kozek-Langenecker S, Sorensen B, Hess J, Spahn DR. Emotional or evidence-based medicine-is there a moral tragedy in haemostatic therapy?. Critical Care (London, England) 2011; Vol. 15, issue 6:462. [PUBMED: 22236360]
73. Kreuz W, Meili E, Peter-Salonen K, Dobrkovska A, Devay J, Haertel S, et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfusion and Apheresis Science 2005;32:239-46. [MEDLINE: 15919241]
74. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
75. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagulation & Fibrinolysis 2005;16:301-10. [MEDLINE: 15870552]
76. Levi M, Jonge E. Clinical relevance of the effects of plasma expanders on coagulation. Seminars in Thrombosis and Hemostasis 2007;33:810-5. [MEDLINE: 18175286]
77. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesthesia and Analgesia 2012;114(2):261-74. [PUBMED: 21965371]
78. Lissalde-Lavigne G, Combescure C, Muller L, Bengler C, Raillard A, Lefrant JY, et al. Simple coagulation tests improve survival prediction in patients with septic shock. Journal of Thrombosis and Haemostasis 2008;6:645-53. [MEDLINE: 18194420]
79. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. The Journal of Trauma 2009;67:202-8. [MEDLINE: 19590336]
80. Moher D, Liberati A, TetzlaffJ, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009;62(10):1006-12. [PUBMED: 19631508]
81. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arteriosclerosis, Thrombosis, and Vascular Biology 2002;22:1381-9. [MEDLINE: 12231555]
82. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Annals of the New York Academy of Sciences 2001;936:11-30. [PUBMED: 11460466]
83. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiologica Scandinavica 2005;49:222-31. [MEDLINE: 15715625]
84. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiologica Scandinavica 2005;49:1163-71. [MEDLINE: 16095459]
85. Ozier Y, Hunt BJ. Against: fibrinogen concentrate for management of bleeding: against indiscriminate use. Journal of Thrombosis and Haemostasis 2011;9(1):6-8. [PUBMED: 21210948]
86. Parasnis H, Raje B, Hinduja IN. Relevance of plasma fibrinogen estimation in obstetric complications. Jourmal of Postgraduate Medicine 1992;38:183-5. [MEDLINE: 1307590]
87. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Controlled Clinical Trials 1997;18(6):580-93. [MEDLINE: 9408720]
88. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998;351(9095):45-52. [MEDLINE: 9433436]
89. Dansk Lægemiddel Information A/S. Information on drugs for professionals, fibrinogen concentrate. http://pro.medicin.dk/Medicin/Praeparater/6505 (accessed 3 April 2013).
90. Rahe-Meyer N, Sorensen B. Fibrinogen concentrate for management of bleeding. Journal of Thrombosis and Haemostasis 2011;9(1):1-5. [PUBMED: 20946151]
91. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
92. CSL Behring. RiSTAP-Full prescribing information. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm094006.pdf (accessed 6 February 2013).
93. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding following major trauma: an updated European guideline. Critical Care (London, England) 2010;14(2):R52. [PUBMED: 20370902]
94. Rucker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine 2008;27:746-63. [MEDLINE: 17592831]
95. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. British Journal of Haematology 2010;149(6):834-43. [MEDLINE: 20456356]
96. Stanworth SJ, Hunt BJ. The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Critical Care (London, England) 2011; Vol. 15, issue 6:1006. [PUBMED: 22082120]
97. Sutton AJ, Cooper NJ, Lambert PC, Jones DR, Abrams KR, Sweeting MJ. Meta-analysis of rare and adverse event data. Expert Review in Pharmacoeconomics Outcomes Research 2002;2:367-79. [MEDLINE: 19807443]
98. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial Sequential Analysis. version 0.8. Copenhagen: Copenhagen Trial Unit, 2010.
99. Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PloS One 2013;8(3):e59202. [PUBMED: 23544056]
100. Ucar HI, Oc M, Tok M, Dogan OF, Oc B, Aydin A, et al. Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. The Heart Surgery Forum 2007;10:E392-6. [MEDLINE: 17855205]
101. United Kingdom Haemophelia Centre Doctors' Organisation. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003;9(1):1-23. [PUBMED: 12558775]
102. Warmuth M, Mad P, Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiologica Scandinavica 2012;56(5):539-48. [PUBMED: 22150561]
103. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75. [MEDLINE: 18083463]
104. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. [PUBMED: 20042080]
105. Wikkelsø A, Lunde J, Johansen M, Stensballe J, Wetterslev J, Møller AM, et al. Fibrinogen concentrate in severely bleeding patients for acquired hypofibrinogenaemia. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD008864]